Offering a potential early intervention for Alzheimer’s disease (AD), researchers at University of California, San Diego School of Medicine and Cenna Biosciences, Inc. have identified compounds that block the production of beta amyloid peptides in mice. The study is reported April 29 in PLOS ONE.
The National Academy of Sciences today elected five professors at the University of California, San Diego, to membership in the prestigious National Academy of Sciences, one of the highest honors bestowed on U.S. scientists and engineers.
Researchers at the University of California, San Diego School of Medicine report that blocking or removing immune-suppressing cells allows a special type of chemotherapy — and the immune cells it activates — to destroy prostate tumors. This novel combination therapy, termed chemoimmunotherapy, achieved near complete remission in mouse models of advanced prostate cancer. The study is published April 29 in Nature.
A new study by researchers at the University of California, San Diego School of Medicine has identified demographic, socioeconomic and cultural factors that contribute to a major gender disparity among U.S. men and women undergoing weight loss surgeries. Men undergo the surgeries in far lower numbers than women.
Cal-BRAIN, a California research grants program that aims to revolutionize our understanding of the brain, has selected 16 projects to receive inaugural seed grants of $120,000 each. The projects represent efforts around the state to create new technologies capable of measuring brain activity in greater depth, breadth and detail than is currently possible.
San Diego community members, physicians and cancer survivors will come together Saturday, April 25 at the Grand Del Mar for SPARK Gala, an evening to “ignite the fight against cancer.”
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
